Based on SEC filing data. A pharmaceutical corporation in La Jolla, CA raised $49.6M through a convertible note at the growth stage. The company is progressing beyond early development with institutional backing to advance its pipeline or operations.
Get notified the moment Orexigen Therapeutics, Inc. files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.